Page last updated: 2024-08-25

bendamustine hydrochloride and Inflammation

bendamustine hydrochloride has been researched along with Inflammation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Argnani, L; Baumgartner, J; Broccoli, A; Carella, M; Casadei, B; Cavo, M; Coppola, PE; Hohensinner, P; Kazem, N; Koller, L; Laufer, G; Lolli, G; Morigi, A; Nanni, L; Niessner, A; Pellegrini, C; Sabattini, E; Stefoni, V; Steinlechner, B; Sulzgruber, P; Thaler, B; Wojta, J; Zinzani, PL	1

Trials

1 trial(s) available for bendamustine hydrochloride and Inflammation

Article	Year
Thrombosis and haemostasis, 2020, Volume: 120, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Atrial Fibrillation; Bendamustine Hydrochloride; C-Reactive Protein; CD28 Antigens; Comorbidity; Coronary Artery Bypass; Cytotoxicity, Immunologic; Elective Surgical Procedures; Female; Follow-Up Studies; Heart Valve Prosthesis Implantation; Humans; Inflammation; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Postoperative Complications; Prognosis; Prospective Studies; Remission Induction; Retrospective Studies; Rituximab; Survival Rate; T-Lymphocyte Subsets	2020

Article

Year

Thrombosis and haemostasis, 2020, Volume: 120, Issue:8

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Atrial Fibrillation; Bendamustine Hydrochloride; C-Reactive Protein; CD28 Antigens; Comorbidity; Coronary Artery Bypass; Cytotoxicity, Immunologic; Elective Surgical Procedures; Female; Follow-Up Studies; Heart Valve Prosthesis Implantation; Humans; Inflammation; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Postoperative Complications; Prognosis; Prospective Studies; Remission Induction; Retrospective Studies; Rituximab; Survival Rate; T-Lymphocyte Subsets

2020